Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
Molecular Genetic Features of Acute Leukemia
Sponsor: Alliance for Clinical Trials in Oncology
This observational or N/A phase trial investigates Acute Lymphoblastic Leukemia and Acute Promyelocytic Leukemia and is currently ongoing. Alliance for Clinical Trials in Oncology leads this study, which shows 15 recorded versions since 1999 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Active Not Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Sep 2023 — Jul 2024 [monthly]
Active Not Recruiting
-
Dec 2021 — Sep 2023 [monthly]
Active Not Recruiting
▶ Show 10 earlier versions
-
Sep 2021 — Dec 2021 [monthly]
Active Not Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Mar 2020 — Nov 2020 [monthly]
Active Not Recruiting
-
Feb 2019 — Mar 2020 [monthly]
Active Not Recruiting
-
Jun 2018 — Feb 2019 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
First recorded
Apr 1999
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Alliance for Clinical Trials in Oncology
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .